Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Resource Library

Safety Consideration for Administering Intravenous and Subcutaneous Prostacyclins to Pulmonary Hypertension Patients in the Hospital Setting

Martha Kingman

Jennifer Priziola

K. Jones


  Sign in to add a review

Leave a Comment

Conference: 2011 PH Professional Network Symposium

Release Date: 09.22.2011

Presentation Type: Abstracts

M Kingman, DNP1; J Priziola, PharmD, BCPs2; K Jones, RN3 

1. University of Texas Southwestern Medical Center at Dallas 
2. William Beaumont Hospital
3. University of Texas Southwestern Medical Center at Dallas

PURPOSE: This project involved developing recommendations for the safe administration of IV and SQ prostacyclin medications in the hospital setting.

BACKGROUND: Prostacyclin errors are not uncommon and can be life-threatening.

METHODOLOGY: Phase 1 -National survey identified common errors and best safety practices. Phase 2- Development of safety recommendations which included safety measures from other high risk medications, and input from PHRN and SLC of PHA.

FINDINGS/OUTCOME: Creation of safety considerations for IV/SQ prostacyclin inpatient policies.

IMPLICATIONS: Prostacyclin infusion errors occur and safety practices should be considered. Further research, should be conducted to better determine effectiveness of safety measures.